ARTICLE | Clinical News
Protegrin IB-367 rinse: Completed Phase III study
January 22, 2001 8:00 AM UTC
IntraBiotics Pharmaceuticals Inc. (IBPI), Mountain View, Calif. Product: Protegrin IB-367 rinse Business: Infectious diseases Therapeutic category: Bacterial infection Target: Bacterial cell membranes...